OTCMKTS:TPIY Tianyin Pharmaceutical (TPIY) Stock Price, News & Analysis → The Gold Grab of the Century (From Colonial Metals) (Ad) Free TPIY Stock Alerts $0.0001 +0.00 (+∞) (As of 07/15/2019) Add Compare Share Share Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.0001▼$0.0178Volume88,900 shsAverage Volume36,100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Tianyin Pharmaceutical alerts: Email Address Ad Insiders ExposedThe Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! About Tianyin Pharmaceutical Stock (OTCMKTS:TPIY)Tianyin Pharmaceutical Co., Inc. is engaged in the development, manufacturing, marketing and sale of modernized traditional Chinese medicines and other pharmaceuticals in China. Its products address significant medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology and pediatrics. The company was founded on August 20, 2002 and is headquartered in Chengdu, China.Read More TPIY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TPIY Stock News HeadlinesMarch 17, 2023 | wsj.comTasly Pharmaceutical Group Co. Ltd. AMarch 2, 2023 | uk.investing.comTianjin Chase Sun Pharmaceutical Co Ltd (300026)April 30, 2024 | True Market Insiders (Ad)The “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…February 28, 2023 | wsj.comTianjin Chase Sun Pharmaceutical Co. Ltd.February 25, 2023 | seekingalpha.comArrowhead Pharmaceuticals Requires CautionFebruary 23, 2023 | uk.finance.yahoo.comA Look At The Intrinsic Value Of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)February 23, 2023 | wsj.comTianjin Tianyao Pharmaceutical Co. Ltd.February 22, 2023 | morningstar.comTianjin Pharmaceutical Da Ren Tang Group Corp Ltd Class SApril 30, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.February 18, 2023 | marketwatch.comRifampicin Market Analysis by Application like Tuberculosis, Leprosy, Legionnaire's Disease, Others)February 9, 2023 | marketwatch.comPermethrin Spray Market to Grow Exponentially Due to Rising DemandFebruary 8, 2023 | marketwatch.comDoxofylline Tablets Market is set to see Revolutionary growth in decadeFebruary 8, 2023 | marketwatch.comDactinomycin Market is anticipated to boost sales at a Impressive CAGRFebruary 1, 2023 | marketwatch.comCyclopentanone (Cas 120-92-3) Market : Future Growth with Technology and Current Trends 2023 to 2029January 23, 2023 | marketwatch.comMycophenolic Acid Market 2023 : Profiling Key Players, Value Estimation and Analysis by Recent Trends to 2028January 20, 2023 | marketwatch.comDibucaine(Cinchocaine) API Market Size, Share, Growth, Revenue, Demand, Future Potential, and Forecast from 2023 to 2029January 12, 2023 | msn.comSix types of Benylin and Nurofen for children among medicines in short supplySee More Headlines Receive TPIY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tianyin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolOTCMKTS:TPIY Previous SymbolNYSEMKT:TPI CUSIPN/A CIK1362718 Webwww.tianyinpharma.com Phone00-86-028-8551-6696FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta54.39 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesGuo Qing JiangChairman, President & Chief Executive OfficerTao YangChief Operating OfficerLi Ying WangFinancial ControllerYing ZhangDirector-Human ResourcesKey CompetitorsAbliva AB (publ)OTCMKTS:NEVPFAcusphereOTCMKTS:ACUSAddex TherapeuticsOTCMKTS:ADDXFAeolus PharmaceuticalsOTCMKTS:AOLSAffymaxOTCMKTS:AFFYView All Competitors TPIY Stock Analysis - Frequently Asked Questions How have TPIY shares performed in 2024? Tianyin Pharmaceutical's stock was trading at $0.0001 at the beginning of the year. Since then, TPIY shares have increased by 0.0% and is now trading at $0.0001. View the best growth stocks for 2024 here. What other stocks do shareholders of Tianyin Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tianyin Pharmaceutical investors own include International Business Machines (IBM). How do I buy shares of Tianyin Pharmaceutical? Shares of TPIY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TPIY) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tianyin Pharmaceutical Inc Co Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
